Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Uchida

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|October 20, 2021
Alemtuzumab clearance, lymphocyte count, and T-cell chimerism after hematopoietic stem cell transplant in sickle cell diseaseDana Furstenau, Cody J Peer, Thomas E Hughes, et al.
Blood|January 19, 2013
MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathwayChutima Kumkhaek, Wulin Aerbajinai, Wenli Liu, et al.
Transfusion|May 25, 2010
5% dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSOJun Hayakawa, Elizabeth G Joyal, Jean F Gildner, et al.
Human Gene Therapy. Clinical Development|April 28, 2017
Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD PatientsNaoya Uchida, Atsushi Fujita, Matthew M Hsieh, et al.
The Journal of Clinical Investigation|April 6, 2010
Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblastsHong Ye, Suh Young Jeong, Manik C Ghosh, et al.
British Journal of Haematology|April 12, 2019
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, Aylin Bonifacino, Venina M Dominical, et al.
Fertility and Sterility|October 30, 2012
Peripheral blood stem cell transplants do not result in endometrial stromal engraftmentErin F Wolff, Naoya Uchida, Robert E Donahue, et al.
Journal of Equine Science|May 8, 2023
Evaluation of genetic diversity using 31 microsatellites in Miyako horsesMioko Masuda, Akihiro Nikadori, Emi Nikadori, et al.
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient MiceAlexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2020
βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for <i>Ex Vivo</i> Anti-sickling Activity in Human Erythroid CellsSelami Demirci, Bjorg Gudmundsdottir, Quan Li, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|October 20, 2021
Alemtuzumab clearance, lymphocyte count, and T-cell chimerism after hematopoietic stem cell transplant in sickle cell diseaseDana Furstenau, Cody J Peer, Thomas E Hughes, et al.
Blood|January 19, 2013
MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathwayChutima Kumkhaek, Wulin Aerbajinai, Wenli Liu, et al.
Transfusion|May 25, 2010
5% dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSOJun Hayakawa, Elizabeth G Joyal, Jean F Gildner, et al.
Human Gene Therapy. Clinical Development|April 28, 2017
Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD PatientsNaoya Uchida, Atsushi Fujita, Matthew M Hsieh, et al.
The Journal of Clinical Investigation|April 6, 2010
Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblastsHong Ye, Suh Young Jeong, Manik C Ghosh, et al.
British Journal of Haematology|April 12, 2019
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, Aylin Bonifacino, Venina M Dominical, et al.
Fertility and Sterility|October 30, 2012
Peripheral blood stem cell transplants do not result in endometrial stromal engraftmentErin F Wolff, Naoya Uchida, Robert E Donahue, et al.
Journal of Equine Science|May 8, 2023
Evaluation of genetic diversity using 31 microsatellites in Miyako horsesMioko Masuda, Akihiro Nikadori, Emi Nikadori, et al.
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient MiceAlexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2020
βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for <i>Ex Vivo</i> Anti-sickling Activity in Human Erythroid CellsSelami Demirci, Bjorg Gudmundsdottir, Quan Li, et al.
Pageof 9